Anlon Healthcare Limited (NSE:AHCL)

Market Cap	7.36B
Revenue (ttm)	1.72B +43.1%
Net Income	285.14M +39.0%
EPS	6.11 +859.8%
Shares Out	531.52M
PE Ratio	2.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,072,110
Open	14.29
Previous Close	14.25
Day's Range	13.52 - 15.02
52-Week Range	9.08 - 17.28
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumat...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2013
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AHCL

Financial Performance

In fiscal year 2026, Anlon Healthcare's revenue was 1.72 billion, an increase of 43.12% compared to the previous year's 1.20 billion. Earnings were 285.14 million, an increase of 38.97%.